<?xml version="1.0" encoding="utf-8"?>
<feed xmlns="http://www.w3.org/2005/Atom">
	<id>https://www.i-jmr.org/issue/feed</id>
	<title>Interactive Journal of Medical Research</title>
			<updated>2024-01-18T09:15:04-05:00</updated>
	
		<author>
		<name>JMIR Publications</name>
				<email>editor@jmir.org</email>
			</author>
		<link rel="alternate" href="https://www.i-jmr.org" />
	<link rel="self" type="application/atom+xml" href="https://www.i-jmr.org/feed/atom" />

	<generator uri="http://pkp.sfu.ca/ojs/" version="2.2.0.0">Open Journal Systems</generator>

				        <rights> Unless stated otherwise, all articles are open-access distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/3.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work (&quot;first published in the interactive Journal of Medical Research...&quot;) is properly cited with original URL and bibliographic citation information. The complete bibliographic information, a link to the original publication on http://www.i-jmr.org/, as well as this copyright and license information must be included. </rights>
    	<subtitle> A new general medical journal for the 21st century, focusing on innovation in health and medical research. </subtitle>



	<entry>
		<id> https://www.i-jmr.org/2026/1/e83799 </id>
		<title>Identification of the Core Competencies Required in Endodontics for Undergraduate Students in Syrian Dental Schools by Using a Modified Delphi Technique: Prospective Exploratory Survey Study</title>
		<updated>2026-06-09T06:30:03-04:00</updated>

					<author>
				<name>Muhammad Salameh</name>
			</author>
					<author>
				<name>Mayssoon Dashash</name>
			</author>
					<author>
				<name>Issam Jamous</name>
			</author>
				<link rel="alternate" href="https://www.i-jmr.org/2026/1/e83799" />
					<summary type="html" xml:base="https://www.i-jmr.org/2026/1/e83799">&lt;strong&gt;Background:&lt;/strong&gt; There is a worldwide movement toward competency-based medical education to equip dental students with essential competencies required to meet health care needs. In Syria, dental faculties currently lack a formal competency-based curriculum for endodontics at the undergraduate level. Moreover, the quality of root canal treatment performed by general dentists is frequently described as inadequate or substandard. &lt;strong&gt;Objective:&lt;/strong&gt; This study aimed to develop a national consensus on the required competencies for undergraduate endodontics in Syria in order to establish a foundation for a standardized national curriculum, which can guide educators in adopting best practices in both dental education and clinical endodontics. &lt;strong&gt;Methods:&lt;/strong&gt; This study was conducted at Syrian Virtual University between April and June 2025. A modified Delphi technique was used to determine endodontic competencies. Initially, a group of 5 Syrian endodontic consultants identified preliminary competencies. In the first round, 53 experts evaluated these competencies by using a 5-point Likert scale. Based on these results, a second round was conducted with 38 experts. Competencies with a weighted average above 4.20 were considered essential. Data analysis was performed using IBM SPSS package 27, and survey reliability was measured by Cronbach α. &lt;strong&gt;Results:&lt;/strong&gt; Following the final Delphi round, a set of 31 competencies was established, comprising 9 knowledge, 13 skills, and 9 attitudes competencies. Cronbach α was more than 0.9 in the first and second round. The standard deviation across all questionnaires was low (≤0.85). The standard error was also minimal (≤0.12). &lt;strong&gt;Conclusions:&lt;/strong&gt; This study identified a set of core endodontic competencies for the undergraduate level in Syria. These competencies are intended to support students in acquiring the required knowledge, skills, and attitudes, and assisting policymakers in implementing competency-based medical education within Syria and similar contexts. </summary>
		
        
                	<content type="image/png" src="https://jmir-production.s3.us-east-2.amazonaws.com/thumbs/d949ac0a21870175a02784a805283066" />
		
		<published>2026-06-09T06:30:03-04:00</published>
	</entry>
	<entry>
		<id> https://www.i-jmr.org/2026/1/e80616 </id>
		<title>Digital Interventions Addressing Cognitive and Psychological Symptoms in Long COVID: Scoping Review of Multicomponent Approaches</title>
		<updated>2026-06-08T15:45:12-04:00</updated>

					<author>
				<name>Sandra León-Herrera</name>
			</author>
					<author>
				<name>Marta Sánchez-Castro</name>
			</author>
					<author>
				<name>Ana Luisa Neves</name>
			</author>
					<author>
				<name>Mª Pilar Rodríguez-Pérez</name>
			</author>
					<author>
				<name>Vinicius Jobim Fischer</name>
			</author>
					<author>
				<name>Djenna Hutmacher</name>
			</author>
					<author>
				<name>Reham Aldakhil</name>
			</author>
					<author>
				<name>Marina Vaillancourt de Dios</name>
			</author>
					<author>
				<name>Vinicius Anjos de Almeida</name>
			</author>
					<author>
				<name>Bárbara Oliván-Blázquez</name>
			</author>
					<author>
				<name>Rosa Magallón-Botaya</name>
			</author>
					<author>
				<name>Charles Benoy</name>
			</author>
					<author>
				<name>Raquel Gómez-Bravo</name>
			</author>
				<link rel="alternate" href="https://www.i-jmr.org/2026/1/e80616" />
					<summary type="html" xml:base="https://www.i-jmr.org/2026/1/e80616">Background: Long COVID, or postacute COVID-19 syndrome, presents with persistent cognitive and psychological symptoms such as , anxiety, depression, and fatigue, significantly impacting quality of life and daily functioning. Digital health interventions offer a scalable, accessible solution to bridge care gaps, especially where conventional neuropsychological support is limited. However, evidence regarding their effectiveness for neuropsychiatric symptoms in long COVID remains fragmented. Objective: This scoping review aimed to systematically identify and map the existing evidence on digital interventions targeting cognitive and psychological symptoms in individuals with long COVID. The review also sought to categorize intervention types, assess reported outcomes, and identify methodological gaps to inform future clinical and research priorities. Methods: The review followed the Arksey and O’Malley framework and adhered to the PRISMA-ScR (Preferred Reporting Items for Systematic Reviews and Meta-Analyses Extension for Scoping Reviews) guidelines. Comprehensive searches were conducted in 4 databases (PubMed, Scopus, Web of Science, and ScienceDirect) from December 2024 to February 2025. Eligible studies included peer-reviewed and gray literature published in English or Spanish since 2020. Studies were screened and selected based on predefined inclusion and exclusion criteria. Data were extracted using a standardized charting form and synthesized narratively, with thematic grouping by intervention type. Results: Of 888 records identified, 25 (2.82%) were included. Intervention types encompassed telehealth platforms, mobile health apps, virtual reality, online cognitive and psychological therapies, game-based cognitive training, neuromodulation (transcranial direct current stimulation), and multicomponent programs. Most studies reported improvements in psychological well-being, emotional regulation, and cognitive domains such as attention and memory. However, findings varied, with some interventions showing no significant cognitive gains or sustained effects. Common limitations included small sample sizes, lack of control groups, heterogeneity in outcomes and intervention protocols, and short follow-up durations. The underrepresentation of older adults and underserved populations was also noted. Conclusions: Digital interventions show promise for addressing cognitive and psychological symptoms in long COVID, particularly when delivered as multicomponent programs. Nonetheless, the evidence base remains preliminary. Future research should prioritize high-quality randomized trials with standardized outcome measures, long-term follow-up, and diverse participant samples. Addressing barriers related to digital literacy and access will be essential to ensure equity and real-world effectiveness. Trial Registration: OSF Registries 10.17605/OSF.IO/HX7UE; https://osf.io/hx7ue/overview</summary>
		
        
                	<content type="image/png" src="https://jmir-production.s3.us-east-2.amazonaws.com/thumbs/8e031aae3444d17b62623e5dc834fa41" />
		
		<published>2026-06-08T15:45:12-04:00</published>
	</entry>
	<entry>
		<id> https://www.i-jmr.org/2026/1/e80263 </id>
		<title>COVID-19 Rebound in Nirmatrelvir Plus Ritonavir Treatment and Control Groups: Prospective Cohort Study</title>
		<updated>2026-06-02T16:00:05-04:00</updated>

					<author>
				<name>Jacqueline K Kueper</name>
			</author>
					<author>
				<name>Kalyani Kottilil</name>
			</author>
					<author>
				<name>Giorgio Quer</name>
			</author>
					<author>
				<name>Danielle C Chiang</name>
			</author>
					<author>
				<name>Emily G Spencer</name>
			</author>
					<author>
				<name>Jyothi Purushotham</name>
			</author>
					<author>
				<name>Edward Ramos</name>
			</author>
					<author>
				<name>Leila Roumani</name>
			</author>
					<author>
				<name>Kristian G Andersen</name>
			</author>
					<author>
				<name>Eric J Topol</name>
			</author>
					<author>
				<name>Jay A Pandit</name>
			</author>
					<author>
				<name>Michael J Mina</name>
			</author>
				<link rel="alternate" href="https://www.i-jmr.org/2026/1/e80263" />
					<summary type="html" xml:base="https://www.i-jmr.org/2026/1/e80263">Background: Observation of COVID-19 rebound after nirmatrelvir plus ritonavir (NPR) has driven important questions surrounding one of the only direct-acting antiviral treatments for COVID-19. Objective: The objective of this study was to examine the epidemiology of COVID-19 rebound among COVID-19–positive outpatients in the United States who independently decided whether or not to take NPR. Methods: This prospective, decentralized observational cohort study was conducted from August 2022 through December 2023 and included frequent proctored COVID-19 rapid antigen tests and self-report symptom surveys for 15 days. The primary outcome was the incidence of viral and symptom rebound. Secondary outcomes included time to initial viral and symptom clearance, rebound probability among patients who cleared by day 15, and symptom frequency. Results: Of 917 consenting participants, 669 (73%) were eligible for inclusion in the analysis (n=443, 66% in the NPR group; n=226, 34% in the control group). The mean age was 46.1 (SD 12.9) years, 62.6% (n=419) of participants were female, and 49.2% (n=329) had at least one preexisting condition. Overall, 15-day cumulative incidence was higher in the NPR group than the control group for both viral (70/443, 15.8% vs 12/226, 5.3%) and symptom (73/443, 16.5% vs 19/226, 8.4%) rebound. Time to initial viral and symptom clearance was similar between groups, and among those who experienced clearance by day 15, the probability of viral rebound (NPR: 19.1%, 95% CI 15.1%-24.0% vs control: 7%, 95% CI 4.0%-12.6%; &lt;.001) and symptom rebound (NPR: 47.7%, 95% CI 36.1%-60.8% vs control: 16.9%, 95% CI 10.9%-25.7%; &lt;.001) was higher in the NPR group than the control group. Conclusions: This study demonstrates that while COVID-19 rebound occurs in both NPR-treated and untreated outpatients, the incidence is higher in the NPR group.</summary>
		
        
                	<content type="image/png" src="https://jmir-production.s3.us-east-2.amazonaws.com/thumbs/359f33d4dfc590452bce902af6b3e9fa" />
		
		<published>2026-06-02T16:00:05-04:00</published>
	</entry>
	<entry>
		<id> https://www.i-jmr.org/2026/1/e92969 </id>
		<title>Constructs Influencing Patient Perceptions of Use of AI in Medical Imaging Analysis: Systematic Review</title>
		<updated>2026-06-01T16:30:52-04:00</updated>

					<author>
				<name>Preksha Machaiya Kuppanda</name>
			</author>
					<author>
				<name>Monika Janda</name>
			</author>
					<author>
				<name>Liam J Caffery</name>
			</author>
				<link rel="alternate" href="https://www.i-jmr.org/2026/1/e92969" />
					<summary type="html" xml:base="https://www.i-jmr.org/2026/1/e92969">&lt;strong&gt;Background:&lt;/strong&gt; The use of artificial intelligence (AI) in medical imaging has been growing exponentially. Understanding patient perceptions and factors influencing their views of AI is critical to develop adequate strategies to support implementation and acceptance. &lt;strong&gt;Objective:&lt;/strong&gt; This study aims to investigate the constructs that influence patients’ perceptions and acceptance of AI’s use in the analysis of their medical images to support screening and diagnosis. &lt;strong&gt;Methods:&lt;/strong&gt; A systematic review was conducted to meet the research objective. Relevant articles were found by searching 5 databases. Data were extracted using an iteratively refined framework and synthesized narratively due to heterogeneity in study designs, populations, health care contexts, and outcomes. &lt;strong&gt;Results:&lt;/strong&gt; A total of 59 relevant studies were included in the review. Patient acceptance of AI in medical image analysis emerged from multiple interacting factors. The most consistently reported determinant in 48 studies was that AI implementation should prioritize human-in-the-loop models, positioning AI as supportive tools, working in conjunction with health care providers rather than as an autonomous decision-maker. Other factors identified were performance of the AI, clarity of accountability, trust, and ethical factors. Patients’ individual characteristics such as demographics and health history were also noted to influence acceptance indirectly. The review findings were used to draft a conceptual model to draw attention to the complex relationship among the identified factors. &lt;strong&gt;Conclusions:&lt;/strong&gt; This review informed the development of a conceptual model illustrating the complex and interactive factors shaping patient acceptance of AI in medical imaging, which can be tested prospectively in future studies. Our results highlight that patients’ likelihood of accepting AI cannot be attributed to a few factors. Instead, promoting acceptance will require a holistic approach where multiple factors are considered simultaneously and adapted for each use case. </summary>
		
        
                	<content type="image/png" src="https://jmir-production.s3.us-east-2.amazonaws.com/thumbs/81326acbc1e52cfa01aea0586087e835" />
		
		<published>2026-06-01T16:30:52-04:00</published>
	</entry>
	<entry>
		<id> https://www.i-jmr.org/2026/1/e82088 </id>
		<title>Innovation Deimplementation in Emergency Departments During the COVID-19 Pandemic: Qualitative Study of Clinicians’ Decision-Making</title>
		<updated>2026-05-22T17:15:15-04:00</updated>

					<author>
				<name>Shreya Huilgol</name>
			</author>
					<author>
				<name>Nabeel Qureshi</name>
			</author>
					<author>
				<name>Carl Berdahl</name>
			</author>
					<author>
				<name>Catherine Cohen</name>
			</author>
					<author>
				<name>Peter Mendel</name>
			</author>
					<author>
				<name>Shira Fischer</name>
			</author>
				<link rel="alternate" href="https://www.i-jmr.org/2026/1/e82088" />
					<summary type="html" xml:base="https://www.i-jmr.org/2026/1/e82088">Background: During a public health emergency, emergency department (ED) clinicians can improve care delivery if they identify and adopt innovations that are safe and effective. However, little is known about the factors that impact ED clinicians’ decision-making around using or discontinuing innovations when evidence-based information is limited. Objective: The goal of this study was to understand the processes and factors that led ED clinicians to discontinue (deimplement) the use of COVID-19 care innovations. Methods: This is a qualitative study using semistructured focus groups with ED clinicians from 8 hospitals across the United States. Hospitals were purposively sampled and recruited to capture a diversity of perspectives based on location, facility type (academic or community hospital), rurality (urban or rural), and safety-net status. In this study, 17 physicians, 7 advanced practice providers, 18 nurses, and 7 respiratory therapists participated. We utilized both inductive and deductive techniques to perform content and thematic analysis of transcripts. Results: Clinicians shared that their own experiences (eg, direct observation of patient outcomes), contextual factors, and emerging research evidence contributed heavily to decisions about deimplementing innovations during the COVID-19 pandemic. Processes related to discontinuing innovations depended on leadership guidance and collaboration among colleagues. However, in some cases, there were no official processes to discontinue innovations, and innovations were passively deimplemented. Conclusions: Decision-making regarding the discontinuation of innovation in ED settings during the COVID-19 pandemic differed from routine conditions due to the lack of information and the rapid evolution of evidence within a short period of time. The level of evidence required to implement and deimplement innovations was significantly lower. Our findings indicate that factors influencing deimplementation during a public health emergency were highly localized and were treated similarly to pilot tests of new innovations. Future work is necessary to develop mechanisms for implementing promising innovations during evolving public health emergencies and monitoring their effectiveness and safety after implementation, enabling evidence-based decisions about whether to continue implementation or proceed with deimplementation.</summary>
		
        
                	<content type="image/png" src="https://jmir-production.s3.us-east-2.amazonaws.com/thumbs/f5206a4a415bae4eadfd998bcaac0fcb" />
		
		<published>2026-05-22T17:15:15-04:00</published>
	</entry>
	<entry>
		<id> https://www.i-jmr.org/2026/1/e55866 </id>
		<title>Pulse Discovery Toolkit, a Multicomponent Nutrition Intervention for Preschool Children in Childcare Centers: Mixed Methods Pilot Study</title>
		<updated>2026-05-22T16:45:14-04:00</updated>

					<author>
				<name>Hiwot Abebe Haileslassie</name>
			</author>
					<author>
				<name>Renee Ramikie</name>
			</author>
					<author>
				<name>Hassan Vatanparast</name>
			</author>
					<author>
				<name>D Dan Ramdath</name>
			</author>
					<author>
				<name>Amanda Froehlich Chow</name>
			</author>
					<author>
				<name>Phyllis Shand</name>
			</author>
					<author>
				<name>Rachel Engler-Stringer</name>
			</author>
					<author>
				<name>Jessica R L Lieffers</name>
			</author>
					<author>
				<name>Shannon Hood-Niefer</name>
			</author>
					<author>
				<name>Carol Henry</name>
			</author>
				<link rel="alternate" href="https://www.i-jmr.org/2026/1/e55866" />
					<summary type="html" xml:base="https://www.i-jmr.org/2026/1/e55866">Background: Children’s eating habits are formed at an early age, making childhood a crucial period for introducing novel foods, such as pulse-based food products. Pulse Discovery Toolkit (PDTK) intervention was designed to increase familiarity with pulses and to eventually contribute to the consumption of pulse-based foods among preschool children in childcare centers (CCs). Objective: To determine PDTK’s impact on knowledge, acceptability, and consumption of pulse-based foods among preschool children attending CCs, and to assess its feasibility and acceptability by early childhood educators (ECE) and cooks. The nutrient contents and food group servings of pulse-based intervention recipes in the PDTK were also compared with regular CC recipes. Method: The PDTK intervention was delivered over a 3-month period in 2 CCs in Saskatoon (50 children, 8 staff). The intervention, which integrated taste exposure and nutrition education, consisted of 12 child-friendly weekly lessons, a food service guide for cooks, 15 recipes for pulse-based foods, 4 intervention recipes incorporated in the CC menu, and 4 parent newsletters. Mixed methods were used with pre- and postintervention knowledge tests, plate waste measurement, sensory evaluation, ECE and cook’s perspective, and nutrient content comparison of the intervention and control foods from the regular childcare menu to evaluate the intervention’s impact. Result: Improvements in correct identification of chickpeas (2/21 [10%] at preintervention to 7/21 [33%] at postintervention, =.074), beans (8/21 [38%] to 11/21 [52%], =.68), and peas (6/21 [27%] to 8/21 [38%], =.61) were not statistically significant. Children consumed higher amounts of the regular recipes (293.54, SD 27.65; 178.46, SD 24.33) than the intervention recipes (211.56, SD 25.61; 108.83, SD 21.97) at both times, respectively. However, at the end of the intervention, significant differences were only observed in the amount of total food consumption (=.049) and the protein content (=.04) when consumption proportion was examined, with both being higher for the control recipes in comparison to the intervention recipes. The majority (92% and 72%) of the children rated the refried bean wrap and lentil smoothie, “yummy,” respectively. Most of the intervention recipes have lower energy, fat, and sodium content compared with the regular CC recipes. Findings from ECE semistructured interviews and the lesson plan evaluations revealed that the ECEs reacted favorably to the curriculum. The cooks from the participating CCs did not report any barriers to cooking pulses in their facility. However, the need for modification to make the recipes easier to cook in CCs was noted in our study. Conclusions: With a few modifications to make some of the lessons more age-appropriate and some of the recipes easier to cook, it is feasible to implement the PDTK in CCs in order to promote regular consumption of pulses. International Registered Report Identifier (IRRID): RR2-10.2196/22775</summary>
		
        
                	<content type="image/png" src="https://jmir-production.s3.us-east-2.amazonaws.com/thumbs/aa9b2e54abd5baeb9b0c0d9502bcb7da" />
		
		<published>2026-05-22T16:45:14-04:00</published>
	</entry>
	<entry>
		<id> https://www.i-jmr.org/2026/1/e86448 </id>
		<title>Real‑World Clinical Characterization of Major Depressive Disorder and Treatment‑Resistant Depression Supported by Natural Language Processing: Multicenter Observational Study From the MOOD Project</title>
		<updated>2026-05-22T16:00:04-04:00</updated>

					<author>
				<name>Dieter Zeeuws</name>
			</author>
					<author>
				<name>Katrien Bernagie</name>
			</author>
					<author>
				<name>Geert De Bruecker</name>
			</author>
					<author>
				<name>Isabel Claeys</name>
			</author>
					<author>
				<name>Charlotte Evenepoel</name>
			</author>
					<author>
				<name>Fabienne Ver Donck</name>
			</author>
					<author>
				<name>David Smeets</name>
			</author>
					<author>
				<name>Elke Peeters</name>
			</author>
				<link rel="alternate" href="https://www.i-jmr.org/2026/1/e86448" />
					<summary type="html" xml:base="https://www.i-jmr.org/2026/1/e86448">&lt;strong&gt;Background:&lt;/strong&gt; Major depressive disorder (MDD) and treatment-resistant depression (TRD) are heterogeneous conditions in which key clinical details are split across structured fields and free-text notes in electronic health records (EHRs), constraining population-level insight and timely audit of care quality. &lt;strong&gt;Objective:&lt;/strong&gt; This study aims to present a clinician-oriented, artificial intelligence-supported real-world evidence (RWE) methodology integrating structured and unstructured EHR data to profile MDD and TRD, and report comorbidity patterns from a 2-site pilot. This analysis reports the first objective of the MOOD project, which is to characterize the real‑world clinical and disease severity profile of patients with MDD and treatment‑resistant depression, providing a necessary foundation for subsequent evaluations of treatment patterns and outcomes. &lt;strong&gt;Methods:&lt;/strong&gt; We conducted a retrospective study in 2 Belgian hospitals (September 2021-June 2023). Adults (aged ≥18 years) with MDD were identified via &lt;i&gt;DSM-IV&lt;/i&gt; (&lt;i&gt;Diagnostic and Statistical Manual of Mental Disorders&lt;/i&gt; [Fourth Edition]) and &lt;i&gt;ICD-10&lt;/i&gt; (&lt;i&gt;International Statistical Classification of Diseases, Tenth Revision&lt;/i&gt;) codes or natural language processing-detected note mentions; bipolar depression was excluded. TRD was defined as initiation of a third distinct antidepressant, supplemented by explicit mentions of TRD in notes. Structured data (demographics, diagnoses, medications, and hospitalizations) were harmonized in an Observational Medical Outcomes Partnership warehouse. Free-text notes were processed with a natural language processing pipeline to capture symptoms, psychiatric comorbidities, and contextual events. &lt;strong&gt;Results:&lt;/strong&gt; We identified 1147 adults with MDD, of which 46% (524/1147) met TRD criteria. Females comprised 62.9% (722/1147) and mean (SD) age was 57.8 (18.4) years. Mortality was 13.3% (152/1147) overall (57/1147, 10.9% TRD vs 95/1147, 15.2% non-TRD). Common medical comorbidities were central nervous system diseases (477/1147, 41.6%) and heart diseases (349/1147, 30.4%). Dementia was more frequent in TRD (42/1147, 8% vs 32/1147, 5.1%), whereas obesity was higher in non-TRD (70/1147, 11.2% vs 46/1147, 8.8%). Anxiety disorder occurred in 35.4% (406/1147) overall and was more prevalent in TRD (229/1147, 43.7% vs 177/1147, 28.4%); personality and panic disorders also trended higher. Severity was sparsely documented (severe MDD 170/1147, 14.8%) and standardized scales were rarely recorded. &lt;strong&gt;Conclusions:&lt;/strong&gt; We present a step-by-step artificial intelligence-supported methodology tailored for clinicians, discussing challenges in integrating RWE into psychiatry, and identifying opportunities to enhance data collection with minimal workflow changes, which emphasizes the transformative potential of RWE systems in mental health research. &lt;strong&gt;Trial Registration:&lt;/strong&gt; </summary>
		
        
                	<content type="image/png" src="https://jmir-production.s3.us-east-2.amazonaws.com/thumbs/53987a5e64f1cfc390226ff7eb629374" />
		
		<published>2026-05-22T16:00:04-04:00</published>
	</entry>
	<entry>
		<id> https://www.i-jmr.org/2026/1/e86454 </id>
		<title>Value of Blood Count–Derived Inflammatory Markers for Evaluating Psoriasis Severity: Pilot Cross-Sectional Observational Study</title>
		<updated>2026-05-14T13:15:09-04:00</updated>

					<author>
				<name>Luyuan Wang</name>
			</author>
					<author>
				<name>Xiaorui Zhang</name>
			</author>
					<author>
				<name>Chuangang Xia</name>
			</author>
					<author>
				<name>Wenyu Li</name>
			</author>
					<author>
				<name>Qiuju Li</name>
			</author>
					<author>
				<name>Wen Xiao</name>
			</author>
					<author>
				<name>Youkun Lin</name>
			</author>
				<link rel="alternate" href="https://www.i-jmr.org/2026/1/e86454" />
					<summary type="html" xml:base="https://www.i-jmr.org/2026/1/e86454">Background: Objective indicators are urgently needed to evaluate and monitor disease progression in patients with psoriasis. Objective: This study aimed to verify the correlations between blood count–derived inflammatory markers and the Psoriasis Area and Severity Index (PASI) among patients with psoriasis and explore the value of applying the PASI in combination with proinflammatory factors. Methods: This was a cross-sectional observational study that enrolled 719 patients from 2 tertiary hospitals. Receiver operating characteristic curve analysis and binary logistic regression models were applied to assess the evaluative power of blood count–derived inflammatory markers and their consistency with the PASI for stratifying psoriasis severity. The association with the PASI and the combination with proinflammatory factors of the blood count–derived inflammatory markers in 60 patients were analyzed. The exploratory association between blood count–derived markers and proinflammatory factors was analyzed using product terms. To ensure robustness, multivariable combined models were evaluated using receiver operating characteristic curves and decision curve analysis. Model performance was further validated via calibration plots and a predictive nomogram, with the decision curve analysis net benefit axis increased to 1.0 for comprehensive visualization. Results: The area under the curve showed that the systemic immune-inflammation index (SII), systemic inflammation response index (SIRI), and aggregate index of systemic inflammation (AISI) were effective in reflecting psoriasis severity and showed advantages in patients with psoriasis complicated by arthritis and cardiovascular metabolic diseases. The comprehensive test showed quite appropriate consistency of the SIRI and PASI in distinguishing severity. The SII, SIRI, and AISI were significantly correlated with interleukin (IL)-6 in lesions (all &lt;.05), and the combinations of these indices with IL-6, IL-1, and IL-17 were also significantly correlated with the PASI (all &lt;.05). Conclusions: Blood count–derived inflammatory markers could better reflect the inflammation of patients with psoriasis. The SII, SIRI, and AISI have important clinical significance in evaluating disease severity. The combination with proinflammatory factors showed an advantage.</summary>
		
        
                	<content type="image/png" src="https://jmir-production.s3.us-east-2.amazonaws.com/thumbs/fff9136a45afad141da9bd5288fdebab" />
		
		<published>2026-05-14T13:15:09-04:00</published>
	</entry>
	<entry>
		<id> https://www.i-jmr.org/2026/1/e78073 </id>
		<title>Overcrowding Indicators in Emergency Departments Across Countries: Scoping Review</title>
		<updated>2026-05-05T16:00:09-04:00</updated>

					<author>
				<name>Natasya Nur Mohd Nasir</name>
			</author>
					<author>
				<name>Ku Anis Shazura Indera Putera</name>
			</author>
					<author>
				<name>Nur Jihan Noris</name>
			</author>
					<author>
				<name>Zalina Libasin</name>
			</author>
					<author>
				<name>Muniamal Krishnan</name>
			</author>
					<author>
				<name>Nor Fauziah Salaton</name>
			</author>
					<author>
				<name>Kah Yee Lum</name>
			</author>
					<author>
				<name>Nur Nadia Renu Abdullah</name>
			</author>
					<author>
				<name>Intan Syafinaz Saimy</name>
			</author>
				<link rel="alternate" href="https://www.i-jmr.org/2026/1/e78073" />
					<summary type="html" xml:base="https://www.i-jmr.org/2026/1/e78073">Background: Emergency department (ED) overcrowding is a persistent global health issue associated with adverse patient outcomes, diminished staff performance, and compromised health-system efficiency. Despite widespread recognition of the problem, there is no universally accepted approach to monitoring ED overcrowding. The use of disparate, nonstandardized indicators hampers cross-country comparison and the development of effective policies. A comprehensive synthesis of indicators currently used is essential to guide the adoption of robust, evidence-based metrics across diverse health care settings. Objective: This study aims to identify, consolidate, and categorize indicators that have been used internationally to assess ED overcrowding and to highlight gaps in their use. Methods: A comprehensive scoping review was conducted from October to November 2023 using four databases: PubMed, Scopus, Emerald Insight, and Google Scholar. Studies were systematically searched using predefined eligibility criteria. Level 1 and 2 screening were independently conducted by 9 researchers (NNMN, KASIP, NFS, NJN, MK, ZL, NNRA, LKY, and ISS) to minimize bias and enhance reliability, and discrepancies were resolved by consensus. A third reviewer (ISS) performed a full-text review, synthesis, and descriptive analysis. Indicators were categorized into input, throughput, and output. Input refers to factors driving ED demand, throughput encompasses internal ED processes such as triage, diagnostics, and treatment, and output addresses challenges in transferring patients to inpatient beds, such as bed shortages or delays. Descriptive analyses were then used to consolidate these indicators and to establish their relative importance. They were ranked based on frequency of reporting across diverse countries and health care settings. Results: Out of 1347 articles screened, 117 articles were included in the study. A total of 307 indicators were retrieved and then consolidated into 26 distinct indicators. The majority of indicators were classified within the throughput domain (209/307, 68%), followed by the output domain (62/307, 20%) and the input domain (36/307, 12%). The most common throughput indicator, which was frequently reported, was ED length of stay, cited 87 times, followed by left without being seen and waiting time, each reported 30 times. Length of stay consistently emerged as a primary marker of systemic bottlenecks and operational inefficiencies across health care systems. Conclusions: This review indicates that throughput measures, particularly length of stay, dominate current approaches to assessing ED overcrowding, whereas input and output indicators remain comparatively underrepresented. By consolidating 26 distinct indicators from 117 studies, this study provides a comprehensive evidence base to support the standardization of metrics for monitoring ED overcrowding internationally. These findings offer practical guidance for policymakers and health care leaders seeking to refine performance indicators, enhance benchmarking, and evaluate interventions aimed at improving patient flow. Further research should prioritize validation of underused indicators and the development of composite measures that better capture the complexity of ED crowding across diverse health care settings.</summary>
		
        
                	<content type="image/png" src="https://jmir-production.s3.us-east-2.amazonaws.com/thumbs/2cd9079e5ff2efbe4d2371526bfb04df" />
		
		<published>2026-05-05T16:00:09-04:00</published>
	</entry>
	<entry>
		<id> https://www.i-jmr.org/2026/1/e77011 </id>
		<title>Treating Behavioral Addictions With Augmented Reality and Virtual Reality: Scoping Review</title>
		<updated>2026-04-30T15:00:30-04:00</updated>

					<author>
				<name>Felicia Xin Rou Chiew</name>
			</author>
					<author>
				<name>Genevieve Huimin Li</name>
			</author>
					<author>
				<name>Victrine Tseung</name>
			</author>
					<author>
				<name>Jing Shi</name>
			</author>
				<link rel="alternate" href="https://www.i-jmr.org/2026/1/e77011" />
					<summary type="html" xml:base="https://www.i-jmr.org/2026/1/e77011">&lt;strong&gt;Background:&lt;/strong&gt; The use of augmented reality (AR) and virtual reality (VR) to address addictive behaviors such as substance use disorders and gambling disorders has been growing. However, little has been done to explore the use of AR and VR in the treatment of other behavioral addictions. &lt;strong&gt;Objective:&lt;/strong&gt; This scoping review aims to provide an overview of existing literature on AR and VR interventions for behavioral addictions. Specifically, the research questions are as follows: (1) What behavioral addictions or behavioral harms are being treated using AR and/or VR? (2) What AR and/or VR treatment interventions are being used to treat these behavioral addictions? &lt;strong&gt;Methods:&lt;/strong&gt; This scoping review was conducted based on the framework first proposed by Arksey and O’Malley, later refined by Levac et al, and further outlined in the Joanna Briggs Institute (JBI) Manual for Evidence. The literature was searched in the following databases: CINAHL, PsycArticles, PsycInfo, PubMed, and Web of Science, with Google advanced search complementing the search on Feb 22, 2023. Studies were screened by 2 independent reviewers based on inclusion criteria (all ages; any behavioral addiction, problematic behavior, or behavioral harm; AR or VR treatments and interventions) and exclusion criteria (pornography, sexual, and paraphilic disorders). Discrepancies were resolved by third and fourth reviewers. As this study is a scoping review, risk of bias was not assessed. Data were extracted and presented in tabular form as well as through conceptual analysis as a narrative summary. &lt;strong&gt;Results:&lt;/strong&gt; A total of 9 studies were included in this review, 4 studies on video gaming and 5 studies on gambling behaviors. Participants’ age ranged from 12 to 65 years. Only the use of VR was identified. VR was used as a platform for cue exposure therapy and skills training in both gaming and gambling disorders. VR therapy was effective alone or in combination with other treatments and was comparable to traditional interventions. No adverse effect was reported in the studies. &lt;strong&gt;Conclusions:&lt;/strong&gt; VR is efficacious in treating behavioral addictions and can replace or be used in conjunction with traditional methods. Future directions include using VR with other psychotherapy or relapse prevention, applying VR to treat other addictions, and investigating harmful side effects of VR use. The frequency and duration of sessions can also be optimized. A limitation of this study is that there may be other documents beyond those published and searched in gray literature that could not be included in this review due to time and resource restrictions. The use of AR in the treatment of behavioral addictions did not yield any results in this review. However, VR application in behavioral addiction is promising, potentially efficacious, and capable of multiple applications. &lt;strong&gt;Trial Registration:&lt;/strong&gt; </summary>
		
        
                	<content type="image/png" src="https://jmir-production.s3.us-east-2.amazonaws.com/thumbs/6cc1c8a556bc7a727ee313d136783987" />
		
		<published>2026-04-30T15:00:30-04:00</published>
	</entry>
</feed>